Sponsors (5)
The bill improves safety, donor protections, and federal oversight/traceability for donated human remains and parts, while imposing new compliance costs on institutions and registrants and introducing privacy and federal–state coordination risks.
Students, medical/dental/mortuary schools, and hospitals will have clearer standards for handling donated bodies and parts, reducing safety and biohazard risks.
Donors and their families will receive stronger protections and clearer rules on consent, provenance documentation, and disposition, increasing transparency and respect for donor wishes.
Taxpayers, state governments, researchers, and regulators will gain a federal registration/inspection regime and standardized recordkeeping/reporting that improves oversight, traceability, and data collection on for‑profit dealers and research materials.
Schools, hospitals, nonprofit programs, and small for‑profit registrants will face new administrative and compliance costs (documentation, labeling, training, inspections) plus registration/renewal fees and potential fines, increasing operating expenses.
State governments and registrants may encounter regulatory complexity and coordination burdens because the federal regime could overlap with existing state disposition and anatomical gift laws.
Donors and their families may face increased privacy risks if labeling or records include names and addresses unless regulations tightly limit personally identifiable information.
Based on analysis of 2 sections of legislative text.
Establishes federal requirements for donation, transfer, registration, recordkeeping, disclosures, permissible uses, and HHS oversight of non‑transplant human bodies and body parts used for education and research.
Introduced April 2, 2025 by Gus Bilirakis · Last progress April 2, 2025
Creates a federal regulatory framework for donation, transfer, use, recordkeeping, and sale of whole human bodies and human body parts used for education, research, or advancement of medical, dental, or mortuary science when not intended for transplantation. It requires disclosures and documentation for donors and donor representatives, prohibits certain sales for profit except under a regulated registration regime, mandates institutional policies, training, record retention, reporting to HHS in certain cases, and gives the Secretary of Health and Human Services rulemaking and enforcement authority to implement the requirements and manage registrations for commercial sellers affecting interstate commerce.